O'Connor John James 4

4 · LEMAITRE VASCULAR INC · Filed Mar 30, 2026

AI-generated summary of this filing

Updated Mar 30, 2026

LEMAITRE VASCULAR (LMAT) Director John O'Connor Receives Award

What Happened

John James O'Connor, a director of Lemaitre Vascular, received dividend-equivalent rights that accrue on existing restricted stock unit (RSU) and performance share unit (PSU) awards. On 2026-03-26 he was credited five derivative amounts totaling 3.445 shares (0.394, 0.472, 0.643, 0.728 and 1.208); each was reported at $0.00 per share (derivative awards, not open-market purchases).

Key Details

Transaction date: 2026-03-26; Form 4 filed: 2026-03-30 (timely — within two business days).
Price: $0.00 per share (these are dividend-equivalent rights, reported as derivative awards).
Total reported derivative amount: 3.445 shares across five entries.
Shares owned after transaction: not specified in the provided filing.
Footnotes: F1–F5 indicate these are dividend equivalent rights that accrued on prior awards (RSUs and PSUs granted 12/8/2023, 12/6/2024, and 12/10/2025) and vest proportionately; each right is the economic equivalent of one common share.
No 10b5-1, tax-withholding, or cash sale activity was disclosed in this filing.

Context

These entries reflect dividend-equivalent accruals on existing equity awards — a bookkeeping/compensation event rather than a market buy or sell. Such derivative credits typically convert to shares (or cash) only as the underlying RSUs/PSUs vest; they do not by themselves indicate a purchase or sale decision by the insider.

Form 4

Period: 2026-03-26

Director

Transactions

Award
Dividend Equivalent Rights
[F1]
2026-03-26+0.394→ 4.602 total
→ Common Stock (0.394 underlying)
Award
Dividend Equivalent Rights
[F2]
2026-03-26+0.472→ 4.311 total
→ Common Stock (0.472 underlying)
Award
Dividend Equivalent Rights
[F3]
2026-03-26+0.643→ 3.539 total
→ Common Stock (0.643 underlying)
Award
Dividend Equivalent Rights
[F4]
2026-03-26+0.728→ 3.624 total
→ Common Stock (0.728 underlying)
Award
Dividend Equivalent Rights
[F5]
2026-03-26+1.208→ 1.208 total
→ Common Stock (1.208 underlying)

Footnotes (5)

[F1]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
[F2]These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
[F3]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
[F4]These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
[F5]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Signature

/s/ Laurie A. Churchill, Attorney-in-fact|2026-03-30

1 file